Yasuko Mori, Nobuaki Yoshikura, Takayoshi Shimohata. Slowly Progressive Optic Neuritis During Ravulizumab Therapy in a Patient With Aquaporin‐4 Antibody‐Associated Neuromyelitis Optica Spectrum Disorder. // Clinical and Experimental Neuroimmunology. – 2026. – DOI: 10.1111/cen3.70090. – URL: https://onlinelibrary.wiley.com/doi/10.1111/cen3.70090?af=R
Yasuko Mori, Nobuaki Yoshikura, & Takayoshi Shimohata (2026). Slowly Progressive Optic Neuritis During Ravulizumab Therapy in a Patient With Aquaporin‐4 Antibody‐Associated Neuromyelitis Optica Spectrum Disorder. Clinical and Experimental Neuroimmunology. https://doi.org/10.1111/cen3.70090
Yasuko Mori, et al. “Slowly Progressive Optic Neuritis During Ravulizumab Therapy in a Patient With Aquaporin‐4 Antibody‐Associated Neuromyelitis Optica Spectrum Disorder.” Clinical and Experimental Neuroimmunology, 2026. doi:10.1111/cen3.70090.
@article{Mori2026,
title = {Slowly Progressive Optic Neuritis During Ravulizumab Therapy in a Patient With Aquaporin‐4 Antibody‐Associated Neuromyelitis Optica Spectrum Disorder},
author = {Mori, Yasuko and Yoshikura, Nobuaki and Shimohata, Takayoshi},
journal = {Clinical and Experimental Neuroimmunology},
year = {2026},
doi = {10.1111/cen3.70090},
url = {https://onlinelibrary.wiley.com/doi/10.1111/cen3.70090?af=R}
}